Estrogen increases iNOS expression in the ovine coronary artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Mershon, John L ^a   Baker, R Scott ^a   Clark, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Blood flow; Coronary disease; Hormone; Nitric oxide synthase

Indexed keywords

DEXAMETHASONE; ESTRADIOL; FULVESTRANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DOPPLER FLOWMETER; ESTROGEN ACTIVITY; FEMALE; HEART OUTPUT; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

EID: 0036350484     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00397.2000     Document Type: Article

References (65)

1. Hormone replacement therapy, heart disease, and other considerations
2. 17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS
3. 17β-oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta
4. Nitric oxide and atherosclerosis: Possible implications for therapy
5. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy
6. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte
7. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene
8. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
9. Nitric oxide synthase: Role in the genesis of vascular disease
10. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation
11. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP
12. Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue-specific regulation and induction by cytokines
13. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells
14. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
15. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
16. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
17. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
18. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
19. Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes
20. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase
21. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro
22. Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells
23. Characterization of the human endothelial nitric-oxide synthase promoter
24. Human vascular smooth muscle cells contain functional estrogen receptor
25. Effect of 17β-oestradiol on cytokine-induced nitric oxide produciton in rat isolated aorta
26. Estrogen acutely stimulates endotheial nitric oxide synthase in H 441 human airway epithelial
27. Estrogens increase transcription of the human endothelial NO synthase gene
28. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β-stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
29. Estrogen-induced increases in coronary blood flow are antagonized by inhibitors of nitric oxide synthesis
30. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo
31. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
32. Inducible nitric oxide synthase from human articular chondrosytes: cDNA cloning and analysis of mRNA expression
33. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites
34. Molecular cloning and characterization of human endothelial nitric oxide synthase
35. Mechanisms of estrogen action in the cardiovascular system
36. The protective effects of estrogen on the cardiovascular system
37. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages
38. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones
39. Estrogen and progesterone inhibit vascular smooth muscle proliferation
40. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro
41. Nitric oxide synthases: Roles, tolls, and controls
42. Sex hormones and renal nitric oxide synthetase
43. 17β-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo
44. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues
45. Ovarian steroids in endometrial angiogenesis
46. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
47. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta
48. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
49. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation
50. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
51. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol
52. Post menopausal estrogen therapy and cardiovascular disease: Ten year follow-up from the nurse's health study
53. 17β-estradiol inhibits ovariectomy-induced expression of inducible nitric oxide synthase in rat aorta in vivo
54. Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model
55. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element
56. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase
57. A clinical trial of estrogen-replacement therapy after ischemic stroke
58. Nitric oxide synthases: Gene structure and regulation
59. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin of the cell-specific estrogen-like effects of antiestrogens
60. Induction of calcium-dependent nitric oxide synthases by sex hormones
61. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys
62. The high-output nitric oxide pathway: Role and regulation
63. 17Beta-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells
64. Nonpregnant sheep uterine type I and type III nitric oxide synthase expression is differentially regulated by estrogen
65. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β